These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33386099)

  • 1. Proteochemometrics - recent developments in bioactivity and selectivity modeling.
    Bongers BJ; IJzerman AP; Van Westen GJP
    Drug Discov Today Technol; 2019 Dec; 32-33():89-98. PubMed ID: 33386099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative chemogenomics: machine-learning models of protein-ligand interaction.
    Andersson CR; Gustafsson MG; Strömbergsson H
    Curr Top Med Chem; 2011; 11(15):1978-93. PubMed ID: 21470169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.
    Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR
    Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Learning-Based Modeling of Drug-Target Interaction Prediction Incorporating Binding Site Information of Proteins.
    D'Souza S; Prema KV; Balaji S; Shah R
    Interdiscip Sci; 2023 Jun; 15(2):306-315. PubMed ID: 36967455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visually interpretable models of kinase selectivity related features derived from field-based proteochemometrics.
    Subramanian V; Prusis P; Pietilä LO; Xhaard H; Wohlfahrt G
    J Chem Inf Model; 2013 Nov; 53(11):3021-30. PubMed ID: 24116714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rise of deep learning and transformations in bioactivity prediction power of molecular modeling tools.
    Bule M; Jalalimanesh N; Bayrami Z; Baeeri M; Abdollahi M
    Chem Biol Drug Des; 2021 Nov; 98(5):954-967. PubMed ID: 34532977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery.
    Li Z; Huang R; Xia M; Patterson TA; Hong H
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Consensus Architecture To Improve Performance of Large-Scale Multitask Deep Learning QSAR Models.
    Zakharov AV; Zhao T; Nguyen DT; Peryea T; Sheils T; Yasgar A; Huang R; Southall N; Simeonov A
    J Chem Inf Model; 2019 Nov; 59(11):4613-4624. PubMed ID: 31584270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active learning for computational chemogenomics.
    Reker D; Schneider P; Schneider G; Brown JB
    Future Med Chem; 2017 Mar; 9(4):381-402. PubMed ID: 28263088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational modeling approaches to quantitative structure-binding kinetics relationships in drug discovery.
    De Benedetti PG; Fanelli F
    Drug Discov Today; 2018 Jul; 23(7):1396-1406. PubMed ID: 29574212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Cross-Validation Strategies in Sequence-Based Binding Prediction Using Deep Learning.
    Lopez-Del Rio A; Nonell-Canals A; Vidal D; Perera-Lluna A
    J Chem Inf Model; 2019 Apr; 59(4):1645-1657. PubMed ID: 30730731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of discerning shape in molecular pharmacology.
    Kortagere S; Krasowski MD; Ekins S
    Trends Pharmacol Sci; 2009 Mar; 30(3):138-47. PubMed ID: 19187977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel proteochemometrics model for predicting the inhibition of nine carbonic anhydrase isoforms based on supervised Laplacian score and k-nearest neighbour regression.
    Nazarshodeh E; Sheikhpour R; Gharaghani S; Sarram MA
    SAR QSAR Environ Res; 2018 Jun; 29(6):419-437. PubMed ID: 29882433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of deep and shallow learning methods in chemogenomics for the prediction of drugs specificity.
    Playe B; Stoven V
    J Cheminform; 2020 Feb; 12(1):11. PubMed ID: 33431042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Machine Learning Approach for the Discovery of Ligand-Specific Functional Mechanisms of GPCRs.
    Plante A; Shore DM; Morra G; Khelashvili G; Weinstein H
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31159491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4D- quantitative structure-activity relationship modeling: making a comeback.
    Fourches D; Ash J
    Expert Opin Drug Discov; 2019 Dec; 14(12):1227-1235. PubMed ID: 31513441
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved approach for proteochemometrics modeling: application to organic compound--amine G protein-coupled receptor interactions.
    Lapinsh M; Prusis P; Uhlén S; Wikberg JE
    Bioinformatics; 2005 Dec; 21(23):4289-96. PubMed ID: 16204343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards Proteome-Wide Interaction Models Using the Proteochemometrics Approach.
    Strömbergsson H; Lapins M; Kleywegt GJ; Wikberg JE
    Mol Inform; 2010 Jul; 29(6-7):499-508. PubMed ID: 27463328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinome-Wide Profiling Prediction of Small Molecules.
    Sorgenfrei FA; Fulle S; Merget B
    ChemMedChem; 2018 Mar; 13(6):495-499. PubMed ID: 28544552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.